World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
67
Citations
14258
World Ranking
2691
National Ranking
108

David C. Jackson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where David C. Jackson sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 322 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

David C. Jackson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where David C. Jackson sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 67 D-Index — 47th percentile

47% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

David C. Jackson is affiliated with the University of Melbourne in Australia. Their research primarily focuses on medicine, with significant contributions to immunology and microbiology. The scientist's key subfields include infectious diseases, epidemiology, immunology, molecular biology, and small animal studies.

The main topics in their research involve SARS-CoV-2 and COVID-19 studies, respiratory viral infections, and influenza virus research. Additional areas of focus include immune response and inflammation, COVID-19 clinical research, immunotherapy and immune responses, and immune cell function and interaction.

David C. Jackson has contributed to a variety of scientific journals and publication venues. Frequent venues for their work include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Nature Communications
  • EBioMedicine
  • SSRN Electronic Journal
  • Journal of Clinical Ultrasound

Their recent papers include:

  • Systems serology detects functionally distinct coronavirus antibody features in children and elderly, 2021, Nature Communications
  • Integrated immune dynamics define correlates of COVID-19 severity and antibody responses, 2021, Cell Reports Medicine
  • Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model, 2020, EBioMedicine
  • Immune cellular networks underlying recovery from influenza virus infection in acute hospitalized patients, 2021, Nature Communications
  • CD8+ T cell landscape in Indigenous and non-Indigenous people restricted by influenza mortality-associated HLA-A*24:02 allomorph, 2021, Nature Communications

Collaboration is a notable aspect of Jackson's career. Frequent co-authors include Katherine Kedzierska, Brendon Y. Chua, Chinn Yi Wong, Stephen J. Kent, and Thi H. O. Nguyen. This collaboration network reflects a consistent pattern of teamwork within the fields of immunology and infectious disease research.

The scientist's contributions span multiple disciplines and topics relevant to viral infections and immune function, reflecting an interdisciplinary approach to understanding infectious diseases and immune mechanisms.

Best Publications

  • Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.

    Anika Singanayagam;Anika Singanayagam;Anika Singanayagam;Seran Hakki;Jake Dunning;Jake Dunning;Kieran J Madon

  • Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial.

    Michael D Hill;Mayank Goyal;Bijoy K Menon;Raul G Nogueira

  • Extending thrombolysis to 4·5–9 h and wake-up stroke using perfusion imaging: a systematic review and meta-analysis of individual patient data

    Bruce C V Campbell;Bruce C V Campbell;Henry Ma;Henry Ma;Peter A Ringleb;Mark W Parsons

  • T Cell Allorecognition via Molecular Mimicry

    Whitney Alison Macdonald;Zhenjun Chen;Stephanie Gras;Julia Kate Archbold

  • A totally synthetic vaccine of generic structure that targets Toll-like receptor 2 on dendritic cells and promotes antibody or cytotoxic T cell responses

    David C. Jackson;Yuk Fai Lau;Thuy Le;Andreas Suhrbier

  • Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals.

    Z. Chen;H. Wang;C. D'Souza;S. Sun

  • Reduced Antigenicity of the Hepatitis B Virus HBsAg Protein Arising as a Consequence of Sequence Changes in the Overlapping Polymerase Gene That Are Selected by Lamivudine Therapy

    Joseph Torresi;Linda Earnest-Silveira;Georgia Deliyannis;Kristy Edgtton

  • Inverted repeat structure of the Sry locus in mice.

    John Gubbay;Nigel Vivian;Androulla Economou;David Jackson

  • Bovine and mouse serum beta inhibitors of influenza A viruses are mannose-binding lectins.

    E M Anders;C A Hartley;D C Jackson

  • Human CD8+ T cell cross-reactivity across influenza A, B and C viruses

    Marios Koutsakos;Patricia T. Illing;Thi H. O. Nguyen;Nicole A. Mifsud

  • Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.

    Weiguang Zeng;Souravi Ghosh;Yuk Fai Lau;Lorena E. Brown

  • New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population.

    Evelyn R. Brandt;K.S. Sriprakash;Rhonda I. Hobb;Wendy A. Hayman

  • Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2.

    Hannah H. Alphs;Ratish Gambhira;Ratish Gambhira;Balasubramanyam Karanam;Jeffrey N. Roberts

  • TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.

    Edin Jessica Mifsud;Amabel Chern-Lyn Tan;David Charles Jackson

  • A Randomized, Double-Masked, Placebo-Controlled Clinical Trial of Two Forms of Omega-3 Supplements for Treating Dry Eye Disease.

    Laura A. Deinema;Algis J. Vingrys;Chinn Yi Wong;David C. Jackson

  • Chicken anemia virus VP2 is a novel dual specificity protein phosphatase

    Michelle A. Peters;David C. Jackson;Brendan S. Crabb;Glenn F. Browning

  • Systems serology detects functionally distinct coronavirus antibody features in children and elderly.

    Kevin J. Selva;Carolien E. van de Sandt;Carolien E. van de Sandt;Melissa M. Lemke;Christina Y. Lee

  • Two distinct serum mannose-binding lectins function as beta inhibitors of influenza virus: identification of bovine serum beta inhibitor as conglutinin.

    C A Hartley;D C Jackson;E M Anders

  • Integrated immune dynamics define correlates of COVID-19 severity and antibody responses.

    Marios Koutsakos;Louise C. Rowntree;Luca Hensen;Brendon Y. Chua;Brendon Y. Chua

  • Secondary acylation of Klebsiella pneumoniae lipopolysaccharide contributes to sensitivity to antibacterial peptides.

    Abigail Clements;Dedreia Tull;Adam W Jenney;Jacinta L Farn

Frequent Co-Authors

Lorena E. Brown
Lorena E. Brown University of Melbourne
Joseph Torresi
Joseph Torresi University of Melbourne
Katherine Kedzierska
Katherine Kedzierska University of Melbourne
Jamie Rossjohn
Jamie Rossjohn Monash University
Stephen J. Turner
Stephen J. Turner Monash University
Eric J. Gowans
Eric J. Gowans University of Adelaide
Stephanie Gras
Stephanie Gras La Trobe University
James McCluskey
James McCluskey University of Melbourne
Stephen J. Kent
Stephen J. Kent University of Melbourne
Peter C. Doherty
Peter C. Doherty University of Melbourne

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to diverse healthcare and research careers. For those interested in clinical practice, advancing through specialized nursing roles is a popular path. Programs such as the top psychiatric mental health nurse practitioner programs online offer excellent clinical placement rates, ensuring hands-on experience alongside theoretical knowledge.

Cost is often a major consideration; fortunately, it's possible to find quality education through cheapest psych np programs that balance affordability with accreditation and curriculum rigor. These programs can be a stepping stone into specialized immunology-related mental health roles.

Salary potential also varies by specialization and state. For example, those with a Doctor of Nursing Practice degree might explore different paths with varying compensation. Detailed information on dnp salary by specialty helps prospective students and professionals make informed decisions about their career trajectory within the immunology and healthcare fields.

Additionally, nurses aiming to expand their expertise can consider transitioning to acute care fields. Resources like acute care nurse practitioner programs provide guidance for moving from family nurse practitioner roles into acute care specialties, which often intersect with immunology in patient treatment and research.

Best Scientists Citing David C. Jackson

Trending Scientists

Recently Published Articles